Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection.
about
Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Outcomes and predictors of tre ...... 4 hepatitis C virus infection.
@en
Outcomes and predictors of tre ...... 4 hepatitis C virus infection.
@nl
type
label
Outcomes and predictors of tre ...... 4 hepatitis C virus infection.
@en
Outcomes and predictors of tre ...... 4 hepatitis C virus infection.
@nl
prefLabel
Outcomes and predictors of tre ...... 4 hepatitis C virus infection.
@en
Outcomes and predictors of tre ...... 4 hepatitis C virus infection.
@nl
P2093
P2860
P50
P356
P1476
Outcomes and predictors of tre ...... 4 hepatitis C virus infection.
@en
P2093
Ahmed A Elhadidy
Ahmed I Elshafie
Heba Elashry
Mohamed A Elsebaey
Mohammed H Elnaggar
Ossama A Ahmed
P2860
P304
P356
10.2147/IDR.S160593
P407
P577
2018-03-28T00:00:00Z